NEU trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes NEU achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 28, 2026, NewMarket Corporation (NEU) has a Wall Street consensus price target of N/A, based on estimates from 4 covering analysts. The company has a market capitalization of $7.45B.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, NEU trades at a trailing P/E of 17.8x. Analysts expect EPS to grow -100.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $783.17, with bear and bull scenarios of $493.39 and $1031.90 respectively. Model confidence stands at 43/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
ALBAlbemarle Corporation | $15.8B | $133.70 | $209.75 | +56.9% | Hold | 10.8x | 45 |
IOSPInnospec Inc. | $2.0B | $82.63 | $115.00 | +39.2% | Hold | 17.3x | 9 |
HWKNHawkins, Inc. | $3.4B | $161.59 | — | — | Buy | 41.1x | 1 |
KWRQuaker Chemical Corporation | $2.8B | $160.63 | $176.75 | +10.0% | Buy | 22.9x | 14 |
ECLEcolab Inc. | $79.8B | $283.65 | $326.91 | +15.3% | Buy | 34.1x | 37 |
IFFInternational Flavors & Fragrances Inc. | $19.5B | $76.35 | $88.13 | +15.4% | Buy | 17.2x | 33 |
RPMRPM International Inc. | $14.4B | $112.46 | $124.67 | +10.9% | Buy | 20.5x | 22 |
CBTCabot Corporation | $4.9B | $93.40 | $89.75 | -3.9% | Buy | 14.8x | 15 |
BCPCBalchem Corporation | $5.5B | $171.22 | $175.50 | +2.5% | Buy | 32.7x | 10 |
XOMExxon Mobil Corporation | $566.0B | $136.54 | $170.08 | +24.6% | Hold | 12.4x | 55 |
Quick answers to the most common questions about buying NEU stock.
The consensus price target for NEU is $N/A, close to the current price of $792.82 (N/A% implied move). Based on 4 analyst estimates, the stock appears fairly valued near current levels.
NEU has a consensus rating of "Hold" based on 4 Wall Street analysts. The rating breakdown is leaning bearish, with 2 Sell/Strong Sell ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
NEU's current price is $792.82 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $N/A for NEU, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $1032 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
NEU is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 2 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month NEU stock forecast based on 4 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $783, with bear/bull scenarios of $493/$1032.
Our quantitative valuation model calculates NEU's fair value at $783 (base case), with a bear case of $493 and bull case of $1032. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 43/100.
NEU appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
NEU analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $493-$1032 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.